Eventide Asset Management’s Momenta Pharmaceuticals MNTA Stock Holding History
Bought
Maintained
Sold
Other funds holding MNTA
Eventide Asset Management's MNTA Position: Q3 2020 in Review
Eventide Asset Management sold out of Momenta Pharmaceuticals (MNTA) in Q3 2020, closing a stake of 1,212,000 shares — an estimated $40.3M sold.
Eventide Asset Management first reported a position in MNTA in Q1 2018 and held it in 10 quarters. The position peaked at $40.3M in Q2 2020. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.
- Eventide Asset Management reported no remaining Momenta Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
- Eventide Asset Management sold 1,212,000 Momenta Pharmaceuticals shares in Q3 2020, an estimated $40.3M.
- Eventide Asset Management first reported a position in Momenta Pharmaceuticals in Q1 2018 and held it in 10 quarters.
- Eventide Asset Management's Momenta Pharmaceuticals position peaked at $40.3M in Q2 2020.
- 211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals as of Q3 2020.
Based on Eventide Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.